Sun Pharmaceutical Industries has appointed Mr Israel Makov as Chairman of its board of directors, making clear the Mumbai-based drug-maker's global intentions.
Mr Makov was the former President and Chief Executive of Israeli generic drugs-major Teva Pharmaceutical Industries Ltd, between 2002 and 2007. He is widely credited with Teva's emergence as a global company and a world leader in generic pharmaceuticals, a statement from Sun said.
Mr Makov comes with the knowledge and experience of globalising businesses successfully, said Mr Dilip Shanghvi, Managing Director, Sun Pharma. “As Sun Pharma continues to rapidly expand its presence worldwide, I am sure that we will benefit immensely from his experience,” he added.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.